Records containing: Type 2 Diabetes
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-10-19The Breakfast Study: A Small Steps, Low-literacy, Breakfast-focused Dietary Self-management Intervention for Adults With Poorly Controlled Type 2 Diabetes
-
CLINICAL_TRIALS study results posted · 2026-10-16A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy and Safety of Once Daily Oral Orforglipron Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin (ACHIEVE-2)
-
CLINICAL_TRIALS study results posted · 2026-10-01A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once Daily Oral Orforglipron Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor
-
CLINICAL_TRIALS study results posted · 2026-09-29Food is Medicine: Randomized Trial of Medically-Tailored Food Support for Diabetes Health
-
CLINICAL_TRIALS study results posted · 2026-09-29Intermittent Fasting for the Treatment of Type 2 Diabetes Mellitus
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study results posted · 2026-09-22Continuous Glucose Monitoring Paired With Remotely Delivered Behavior Change Technique Interventions for Glycemic Management and Diabetes Distress Among Adults With Type 2 Diabetes
-
CLINICAL_TRIALS study results posted · 2026-09-15A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy and Safety of Once Daily Oral LY3502970 Compared With Oral Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin (ACHIEVE-3)
-
CLINICAL_TRIALS study results posted · 2026-09-04A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once-Daily Oral LY3502970 Compared With Placebo in Adult Participants With Obesity or Overweight and Type 2 Diabetes (ATTAIN-2)
-
CLINICAL_TRIALS study results posted · 2026-08-31A Phase 2, Parallel-Group, Double-Blind 4-arm Study to Investigate the Effects of Treatment With LY3549492 Tablets Compared With Placebo in an Obese or Overweight Population With Type-2 Diabetes (T2D)
-
CLINICAL_TRIALS study results posted · 2026-08-24Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes: A Follow-up Study
-
CLINICAL_TRIALS study record update · 2026-08-13A Study Investigating Clinical Comparability of Two Formulations of Oral Semaglutide in Japanese Participants With Type 2 Diabetes
-
CLINICAL_TRIALS study results posted · 2026-08-06Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity
-
CLINICAL_TRIALS study record update · 2026-07-30A Master Protocol to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight: A Randomized Double-Blind, Placebo-Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-07-30A Phase III,Multicenter,Randomized,Open-label,Parallel-controlled Study Comparing the Efficacy and Safety of HRS9531 With Semaglutide in Subjects With Type 2 Diabetes Mellitus Not Adequately Controlled With Metformin Monotherapy or in Combination With SGLT2 Inhibitors
-
CLINICAL_TRIALS study results posted · 2026-07-24Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes - FINANCE-DM
-
CLINICAL_TRIALS study results posted · 2026-07-08Optimizing Delivery of Diabetes Management During Breast Cancer Care
-
CLINICAL_TRIALS study results posted · 2026-06-30A Phase 3, Long-term Safety Study of LY3502970 in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone or in Combination With Oral Antihyperglycemic Medications (ACHIEVE-J)
-
CLINICAL_TRIALS study record update · 2026-06-30A Phase 3, Randomized, Double-blinded Study to Evaluate the Efficacy and Safety of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin (OUTSTAND-2)
-
CLINICAL_TRIALS study results posted · 2026-06-22Associations of Early Add-On GLP-1 Receptor Agonist and SGLT2 Inhibitor Therapy With Mortality and Kidney Outcomes in Adults With Obesity and Type 2 Diabetes Across Cardiovascular-Kidney-Metabolic Stages 2-3: A Target-Trial Emulation
-
CLINICAL_TRIALS study results posted · 2026-06-18Personalized Dietary Management in Type 2 Diabetes
-
CLINICAL_TRIALS study results posted · 2026-06-16Family-Based, Culturally-Centered Diabetes Intervention With Ojibwe Communities
-
CLINICAL_TRIALS study results posted · 2026-06-15Ensuring the Cultural Relevance of Dietary Guidelines Diet Patterns Among African Americans: Increasing Dietary Quality and Reducing Type 2 Diabetes Risk
-
CLINICAL_TRIALS study results posted · 2026-06-08Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients: The INFINITI Study
-
CLINICAL_TRIALS study record update · 2026-06-08Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients: The INFINITI Study
-
CLINICAL_TRIALS study record update · 2026-06-05A 40-week Study Comparing the Efficacy and Safety of Once Weekly IcoSema and Daily Insulin Glargine 100 Units/mL in Participants With Type 2 Diabetes Inadequately Controlled on Oral Anti Diabetic Drugs COMBINE 4